Blood Thinning Drugs may Reduce Risk of Repeated Miscarriages

by Kathy Jones on June 30, 2014 at 11:06 PM
 Blood Thinning Drugs may Reduce Risk of Repeated Miscarriages

A fertility clinic in Britain has found that providing blood thinning drugs such as aspirin can help reduce repeated miscarriages in women.

Researchers at IVF treatment clinic Care Facility found that around 44 percent of their patients seeking IVF treatment carried a faulty gene, called C4/M2 that was responsible for repeated miscarriages. Providing the blood thinning treatment can fix the faulty gene, significantly reduce the risk of repeated miscarriages and increase the healthy baby birth rate to 38 per cent.


"It's blood thinning treatment - it's a drug called heparin - possibly even aspirin, but we're studying that at the moment. Those women who have had very poor prognosis can now have the chance of a live birth similar to people who don't have this problem. We studied our IVF patients and found that 44 per cent of couples carried the gene. This is the first time in the world where it has been found that a man can carry a gene that can pass on miscarriage to a woman", Care Facility managing director Professor Simon Fishel said.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Drug News

Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Blood Thinning Drugs may Reduce Risk of Repeated Miscarriages Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests